ブリストル・スケール (Japanese Wikipedia)

Analysis of information sources in references of the Wikipedia article "ブリストル・スケール" in Japanese language version.

refsWebsite

Global rank Japanese rank

70nih.gov

4^th place

24^th place

42doi.org

2^nd place

6^th place

1gutsense.org

low place

1ajou.ac.kr

low place

1medscape.com

719^th place

3,311^th place

1archives-ouvertes.fr

1,031^st place

8,733^rd place

1umich.edu

459^th place

1,980^th place

1books.google.com

3^rd place

61^st place

ajou.ac.kr

repository.ajou.ac.kr

Chung, JM.; Lee, SD.; Kang, DI.; Kwon, DD.; Kim, KS.; Kim, SY.; Kim, HG.; Moon, du G. et al. (July 2010). “An epidemiologic study of voiding and bowel habits in Korean children: a nationwide multicenter study”. Urology 76 (1): 215–9. doi:10.1016/j.urology.2009.12.022. PMID 20163840.

archives-ouvertes.fr

hal.archives-ouvertes.fr

Clemens, KE.; Quednau, I.; Klaschik, E. (April 2011). “Bowel function during pain therapy with oxycodone/naloxone prolonged-release tablets in patients with advanced cancer”. Int J Clin Pract 65 (4): 472–8. doi:10.1111/j.1742-1241.2011.02634.x. PMID 21401835.

books.google.com

Leader, Lucille; Leader, Serena; Leader, Geoffrey (2009). Medical Collaboration for Nutritional Therapists. Denor Press. p. 56. ISBN 9780952605652

doi.org

Amarenco G (2014). “Bristol Stool Chart: étude prospective et monocentrique de "l'introspection fécale" chez des sujets volontaires [Bristol Stool Chart: Prospective and monocentric study of 'stools introspection' in healthy subjects]” (フランス語). Progrès en Urologie 24 (11): 708–13. doi:10.1016/j.purol.2014.06.008. PMID 25214452.
Koh, H.; Lee, MJ.; Kim, MJ.; Shin, JI.; Chung, KS. (February 2010). “Simple diagnostic approach to childhood fecal retention using the Leech score and Bristol stool form scale in medical practice”. J Gastroenterol Hepatol 25 (2): 334–8. doi:10.1111/j.1440-1746.2009.06015.x. PMID 19817956.
Corsetti, M.; De Nardi, P.; Di Pietro, S.; Passaretti, S.; Testoni, PA.; Staudacher, C. (December 2009). “Rectal distensibility and symptoms after stapled and Milligan-Morgan operation for hemorrhoids”. J Gastrointest Surg 13 (12): 2245–51. doi:10.1007/s11605-009-0983-7. PMID 19672663.
Wang, HJ.; Liang, XM.; Yu, ZL.; Zhou, LY.; Lin, SR.; Geraint, M. (2004). “A Randomised, Controlled Comparison of Low-Dose Polyethylene Glycol 3350 plus Electrolytes with Ispaghula Husk in the Treatment of Adults with Chronic Functional Constipation”. Clin Drug Investig 24 (10): 569–76. doi:10.2165/00044011-200424100-00002. PMID 17523718.
Mínguez Pérez, M.; Benages Martínez, A. (May 2009). “The Bristol scale - a useful system to assess stool form?”. Rev Esp Enferm Dig 101 (5): 305–11. doi:10.4321/s1130-01082009000500001. PMID 19527075.
“Rome Criteria and a Diagnostic Approach to Irritable Bowel Syndrome.”. J Clin Med 6 (11): 99. (2017). doi:10.3390/jcm6110099. PMC 5704116. PMID 29072609.
Lewis, SJ.; Heaton, KW. (September 1997). “Stool form scale as a useful guide to intestinal transit time”. Scand J Gastroenterol 32 (9): 920–4. doi:10.3109/00365529709011203. PMID 9299672.
Longstreth, GF.; Thompson, WG.; Chey, WD.; Houghton, LA.; Mearin, F.; Spiller, RC. (April 2006). “Functional bowel disorders”. Gastroenterology 130 (5): 1480–91. doi:10.1053/j.gastro.2005.11.061. PMID 16678561.
Yilmaz, S.; Dursun, M.; Ertem, M.; Canoruc, F.; Turhanoğlu, A. (March 2005). “The epidemiological aspects of irritable bowel syndrome in Southeastern Anatolia: a stratified randomised community-based study”. Int J Clin Pract 59 (3): 361–9. doi:10.1111/j.1742-1241.2004.00377.x. PMID 15857337.
Adibi, P.; Behzad, E.; Pirzadeh, S.; Mohseni, M. (August 2007). “Bowel habit reference values and abnormalities in young Iranian healthy adults”. Dig Dis Sci 52 (8): 1810–3. doi:10.1007/s10620-006-9509-2. PMID 17410463.
Macmillan, AK.; Merrie, AE.; Marshall, RJ.; Parry, BR. (October 2008). “Design and validation of a comprehensive fecal incontinence questionnaire”. Dis Colon Rectum 51 (10): 1502–22. doi:10.1007/s10350-008-9301-9. PMID 18626716.
Chung, JM.; Lee, SD.; Kang, DI.; Kwon, DD.; Kim, KS.; Kim, SY.; Kim, HG.; Moon, du G. et al. (July 2010). “An epidemiologic study of voiding and bowel habits in Korean children: a nationwide multicenter study”. Urology 76 (1): 215–9. doi:10.1016/j.urology.2009.12.022. PMID 20163840.
Maestre, Y.; Parés, D.; Vial, M.; Bohle, B.; Sala, M.; Grande, L. (June 2010). “Prevalence of fecal incontinence and its relationship with bowel habit in patients attended in primary care”. Med Clin (Barc) 135 (2): 59–62. doi:10.1016/j.medcli.2010.01.031. PMID 20416902.
El-Gazzaz, G.; Zutshi, M.; Salcedo, L.; Hammel, J.; Rackley, R.; Hull, T. (December 2009). “Sacral neuromodulation for the treatment of fecal incontinence and urinary incontinence in female patients: long-term follow-up”. Int J Colorectal Dis 24 (12): 1377–81. doi:10.1007/s00384-009-0745-8. PMID 19488765.
Tinmouth, J.; Tomlinson, G.; Kandel, G.; Walmsley, S.; Steinhart, HA.; Glazier, R. (2007). “Evaluation of Stool frequency and stool form as measures of HIV-related diarrhea”. HIV Clin Trials 8 (6): 421–8. doi:10.1310/hct0806-421. PMID 18042507.
Zutshi, M.; Tracey, TH.; Bast, J.; Halverson, A.; Na, J. (June 2009). “Ten-year outcome after anal sphincter repair for fecal incontinence”. Dis Colon Rectum 52 (6): 1089–94. doi:10.1007/DCR.0b013e3181a0a79c. PMID 19581851.
Park, JM.; Choi, MG.; Cho, YK.; Lee, IS.; Kim, JI.; Kim, SW.; Chung, IS. (July 2011). “Functional Gastrointestinal Disorders Diagnosed by Rome III Questionnaire in Korea”. J Neurogastroenterol Motil 17 (3): 279–86. doi:10.5056/jnm.2011.17.3.279. PMC 3155064. PMID 21860820.
Dong, YY.; Zuo, XL.; Li, CQ.; Yu, YB.; Zhao, QJ.; Li, YQ. (September 2010). “Prevalence of irritable bowel syndrome in Chinese college and university students assessed using Rome III criteria”. World J Gastroenterol 16 (33): 4221–6. doi:10.3748/wjg.v16.i33.4221. PMC 2932929. PMID 20806442.
Sorouri, M.; Pourhoseingholi, MA.; Vahedi, M.; Safaee, A.; Moghimi-Dehkordi, B.; Pourhoseingholi, A.; Habibi, M.; Zali, MR. (2010). “Functional bowel disorders in Iranian population using Rome III criteria”. Saudi J Gastroenterol 16 (3): 154–60. doi:10.4103/1319-3767.65183. PMC 3003223. PMID 20616409.
Engsbro, AL.; Simren, M.; Bytzer, P. (February 2012). “Short-term stability of subtypes in the irritable bowel syndrome: prospective evaluation using the Rome III classification”. Aliment Pharmacol Ther 35 (3): 350–9. doi:10.1111/j.1365-2036.2011.04948.x. PMID 22176384.
Ersryd, A.; Posserud, I.; Abrahamsson, H.; Simrén, M. (2007-07-02). “Subtyping the irritable bowel syndrome by predominant bowel habit: Rome II versus Rome III”. Alimentary Pharmacology & Therapeutics 26 (6): 953–961. doi:10.1111/j.1365-2036.2007.03422.x. PMID 17767480.
Choung, RS.; Locke, GR.; Zinsmeister, AR.; Schleck, CD.; Talley, NJ. (October 2007). “Epidemiology of slow and fast colonic transit using a scale of stool form in a community”. Aliment Pharmacol Ther 26 (7): 1043–50. doi:10.1111/j.1365-2036.2007.03456.x. PMID 17877511.
Remes-Troche, JM.; Ozturk, R.; Philips, C.; Stessman, M.; Rao, SS. (February 2008). “Cholestyramine--a useful adjunct for the treatment of patients with fecal incontinence”. Int J Colorectal Dis 23 (2): 189–94. doi:10.1007/s00384-007-0391-y. PMID 17938939.
Wang, HJ.; Liang, XM.; Yu, ZL.; Zhou, LY.; Lin, SR.; Geraint, M. (2004). “A Randomised, Controlled Comparison of Low-Dose Polyethylene Glycol 3350 plus Electrolytes with Ispaghula Husk in the Treatment of Adults with Chronic Functional Constipation”. Clin Drug Investig 24 (10): 569–76. doi:10.2165/00044011-200424100-00002. PMID 17523718.
Sakai, T.; Makino, H.; Ishikawa, E.; Oishi, K.; Kushiro, A. (June 2011). “Fermented milk containing Lactobacillus casei strain Shirota reduces incidence of hard or lumpy stools in healthy population”. Int J Food Sci Nutr 62 (4): 423–30. doi:10.3109/09637486.2010.542408. PMID 21322768.
Riezzo, G.; Orlando, A.; D'Attoma, B.; Guerra, V.; Valerio, F.; Lavermicocca, P.; De Candia, S. (February 2012). “Randomised clinical trial: efficacy of Lactobacillus paracasei-enriched artichokes in the treatment of patients with functional constipation - a double-blind, controlled, crossover study”. Aliment Pharmacol Ther 35 (4): 441–50. doi:10.1111/j.1365-2036.2011.04970.x. PMID 22225544.
Park, JE.; Sul, JU.; Kang, K.; Shin, BC.; Hong, KE.; Choi, SM. (2011). “The effectiveness of moxibustion for the treatment of functional constipation: a randomized, sham-controlled, patient blinded, pilot clinical trial”. BMC Complement Altern Med 11: 124. doi:10.1186/1472-6882-11-124. PMC 3248868. PMID 22132755.
Fosnes, GS.; Lydersen, S.; Farup, PG. (2011). “Effectiveness of laxatives in elderly--a cross sectional study in nursing homes”. BMC Geriatr 11: 76. doi:10.1186/1471-2318-11-76. PMC 3226585. PMID 22093137.
Munshi, R.; Bhalerao, S.; Rathi, P.; Kuber, VV.; Nipanikar, SU.; Kadbhane, KP. (July 2011). “An open-label, prospective clinical study to evaluate the efficacy and safety of TLPL/AY/01/2008 in the management of functional constipation”. J Ayurveda Integr Med 2 (3): 144–52. doi:10.4103/0975-9476.85554. PMC 3193686. PMID 22022157.
Pucciani, F.; Raggioli, M.; Ringressi, MN. (December 2011). “Usefulness of psyllium in rehabilitation of obstructed defecation”. Tech Coloproctol 15 (4): 377–83. doi:10.1007/s10151-011-0722-4. PMID 21779973.
Bafutto, M.; Almeida, JR.; Leite, NV.; Oliveira, EC.; Gabriel-Neto, S.; Rezende-Filho, J. (2011). “Treatment of postinfectious irritable bowel syndrome and noninfective irritable bowel syndrome with mesalazine”. Arq Gastroenterol 48 (1): 36–40. doi:10.1590/s0004-28032011000100008. PMID 21537540.
Michna, E.; Blonsky, ER.; Schulman, S.; Tzanis, E.; Manley, A.; Zhang, H.; Iyer, S.; Randazzo, B. (May 2011). “Subcutaneous methylnaltrexone for treatment of opioid-induced constipation in patients with chronic, nonmalignant pain: a randomized controlled study.”. J Pain 12 (5): 554–62. doi:10.1016/j.jpain.2010.11.008. PMID 21429809.
Clemens, KE.; Quednau, I.; Klaschik, E. (April 2011). “Bowel function during pain therapy with oxycodone/naloxone prolonged-release tablets in patients with advanced cancer”. Int J Clin Pract 65 (4): 472–8. doi:10.1111/j.1742-1241.2011.02634.x. PMID 21401835.
Strid, H.; Simrén, M.; Störsrud, S.; Stotzer, PO.; Sadik, R. (June 2011). “Effect of heavy exercise on gastrointestinal transit in endurance athletes”. Scand J Gastroenterol 46 (6): 673–7. doi:10.3109/00365521.2011.558110. PMID 21366388.
“Stool form scale as a useful guide to intestinal transit time”. Scand. J. Gastroenterol. 32 (9): 920–4. (September 1997). doi:10.3109/00365529709011203. PMID 9299672.
Heaton, KW.; Radvan, J.; Cripps, H.; Mountford, RA.; Braddon, FE.; Hughes, AO. (June 1992). “Defecation frequency and timing, and stool form in the general population: a prospective study”. Gut 33 (6): 818–24. doi:10.1136/gut.33.6.818. PMC 1379343. PMID 1624166.
“Evaluation of gastrointestinal transit in clinical practice: position paper of the American and European Neurogastroenterology and Motility Societies”. Neurogastroenterol. Motil. 23 (1): 8–23. (2011). doi:10.1111/j.1365-2982.2010.01612.x. PMID 21138500.
Parés, D.; Comas, M.; Dorcaratto, D.; Araujo, MI.; Vial, M.; Bohle, B.; Pera, M.; Grande, L. (May 2009). “Adaptation and validation of the Bristol scale stool form translated into the Spanish language among health professionals and patients”. Rev Esp Enferm Dig 101 (5): 312–6. doi:10.4321/s1130-01082009000500002. PMID 19527076.
Martinez, AP; de Azevedo, GR. (2012). “The Bristol Stool Form Scale: its translation to Portuguese, cultural adaptation and validation”. Rev Lat Am Enfermagem 20 (3): 583–589. doi:10.1590/S0104-11692012000300021. PMID 22991122.
Wojtyniak, K.; Szajewska, H.; Dziechciarz, P. (2018). “Translation to Polish, cross-cultural adaptation, and validation of the Bristol Stool Form Scale among healthcare professionals and patients” (英語). Prz Gastroenterol 13 (1): 35–39. doi:10.5114/pg.2017.70610. PMC 5894444. PMID 29657609. Fig. 1: Polish BSFS (CC BY-NC-SA 4.0)
Chumpitazi, BP.; Lane, MM.; Czyzewski, DI.; Weidler, EM.; Swank, PR.; Shulman, RJ. (October 2010). “Creation and initial evaluation of a stool form scale for children”. J Pediatr 157 (4): 594–7. doi:10.1016/j.jpeds.2010.04.040. PMC 2937014. PMID 20826285.
Lane, MM.; Czyzewski, DI.; Chumpitazi, BP.; Shulman, RJ. (September 2011). “Reliability and validity of a modified Bristol Stool Form Scale for children”. J Pediatr 159 (3): 437–441.e1. doi:10.1016/j.jpeds.2011.03.002. PMC 3741451. PMID 21489557.

gutsense.org

Gut Sense What Exactly Are Normal Stools?, Konstantin Monastyrsky. Accessed July 2015

medscape.com

Ersryd, A.; Posserud, I.; Abrahamsson, H.; Simrén, M. (2007-07-02). “Subtyping the irritable bowel syndrome by predominant bowel habit: Rome II versus Rome III”. Alimentary Pharmacology & Therapeutics 26 (6): 953–961. doi:10.1111/j.1365-2036.2007.03422.x. PMID 17767480.

nih.gov

pubmed.ncbi.nlm.nih.gov

Amarenco G (2014). “Bristol Stool Chart: étude prospective et monocentrique de "l'introspection fécale" chez des sujets volontaires [Bristol Stool Chart: Prospective and monocentric study of 'stools introspection' in healthy subjects]” (フランス語). Progrès en Urologie 24 (11): 708–13. doi:10.1016/j.purol.2014.06.008. PMID 25214452.
Koh, H.; Lee, MJ.; Kim, MJ.; Shin, JI.; Chung, KS. (February 2010). “Simple diagnostic approach to childhood fecal retention using the Leech score and Bristol stool form scale in medical practice”. J Gastroenterol Hepatol 25 (2): 334–8. doi:10.1111/j.1440-1746.2009.06015.x. PMID 19817956.
Corsetti, M.; De Nardi, P.; Di Pietro, S.; Passaretti, S.; Testoni, PA.; Staudacher, C. (December 2009). “Rectal distensibility and symptoms after stapled and Milligan-Morgan operation for hemorrhoids”. J Gastrointest Surg 13 (12): 2245–51. doi:10.1007/s11605-009-0983-7. PMID 19672663.
Wang, HJ.; Liang, XM.; Yu, ZL.; Zhou, LY.; Lin, SR.; Geraint, M. (2004). “A Randomised, Controlled Comparison of Low-Dose Polyethylene Glycol 3350 plus Electrolytes with Ispaghula Husk in the Treatment of Adults with Chronic Functional Constipation”. Clin Drug Investig 24 (10): 569–76. doi:10.2165/00044011-200424100-00002. PMID 17523718.
National Collaborating Centre for Nursing and Supportive Care, (UK) (February 2008). Irritable Bowel Syndrome in Adults: Diagnosis and Management of Irritable Bowel Syndrome in Primary Care, NICE Clinical Guidelines, No. 61. PMID 21656972 2015年11月17日閲覧。.
Mínguez Pérez, M.; Benages Martínez, A. (May 2009). “The Bristol scale - a useful system to assess stool form?”. Rev Esp Enferm Dig 101 (5): 305–11. doi:10.4321/s1130-01082009000500001. PMID 19527075.
“Rome Criteria and a Diagnostic Approach to Irritable Bowel Syndrome.”. J Clin Med 6 (11): 99. (2017). doi:10.3390/jcm6110099. PMC 5704116. PMID 29072609.
Lewis, SJ.; Heaton, KW. (September 1997). “Stool form scale as a useful guide to intestinal transit time”. Scand J Gastroenterol 32 (9): 920–4. doi:10.3109/00365529709011203. PMID 9299672.
Longstreth, GF.; Thompson, WG.; Chey, WD.; Houghton, LA.; Mearin, F.; Spiller, RC. (April 2006). “Functional bowel disorders”. Gastroenterology 130 (5): 1480–91. doi:10.1053/j.gastro.2005.11.061. PMID 16678561.
Yilmaz, S.; Dursun, M.; Ertem, M.; Canoruc, F.; Turhanoğlu, A. (March 2005). “The epidemiological aspects of irritable bowel syndrome in Southeastern Anatolia: a stratified randomised community-based study”. Int J Clin Pract 59 (3): 361–9. doi:10.1111/j.1742-1241.2004.00377.x. PMID 15857337.
Adibi, P.; Behzad, E.; Pirzadeh, S.; Mohseni, M. (August 2007). “Bowel habit reference values and abnormalities in young Iranian healthy adults”. Dig Dis Sci 52 (8): 1810–3. doi:10.1007/s10620-006-9509-2. PMID 17410463.
Macmillan, AK.; Merrie, AE.; Marshall, RJ.; Parry, BR. (October 2008). “Design and validation of a comprehensive fecal incontinence questionnaire”. Dis Colon Rectum 51 (10): 1502–22. doi:10.1007/s10350-008-9301-9. PMID 18626716.
Chung, JM.; Lee, SD.; Kang, DI.; Kwon, DD.; Kim, KS.; Kim, SY.; Kim, HG.; Moon, du G. et al. (July 2010). “An epidemiologic study of voiding and bowel habits in Korean children: a nationwide multicenter study”. Urology 76 (1): 215–9. doi:10.1016/j.urology.2009.12.022. PMID 20163840.
Maestre, Y.; Parés, D.; Vial, M.; Bohle, B.; Sala, M.; Grande, L. (June 2010). “Prevalence of fecal incontinence and its relationship with bowel habit in patients attended in primary care”. Med Clin (Barc) 135 (2): 59–62. doi:10.1016/j.medcli.2010.01.031. PMID 20416902.
El-Gazzaz, G.; Zutshi, M.; Salcedo, L.; Hammel, J.; Rackley, R.; Hull, T. (December 2009). “Sacral neuromodulation for the treatment of fecal incontinence and urinary incontinence in female patients: long-term follow-up”. Int J Colorectal Dis 24 (12): 1377–81. doi:10.1007/s00384-009-0745-8. PMID 19488765.
Tinmouth, J.; Tomlinson, G.; Kandel, G.; Walmsley, S.; Steinhart, HA.; Glazier, R. (2007). “Evaluation of Stool frequency and stool form as measures of HIV-related diarrhea”. HIV Clin Trials 8 (6): 421–8. doi:10.1310/hct0806-421. PMID 18042507.
Zutshi, M.; Tracey, TH.; Bast, J.; Halverson, A.; Na, J. (June 2009). “Ten-year outcome after anal sphincter repair for fecal incontinence”. Dis Colon Rectum 52 (6): 1089–94. doi:10.1007/DCR.0b013e3181a0a79c. PMID 19581851.
Park, JM.; Choi, MG.; Cho, YK.; Lee, IS.; Kim, JI.; Kim, SW.; Chung, IS. (July 2011). “Functional Gastrointestinal Disorders Diagnosed by Rome III Questionnaire in Korea”. J Neurogastroenterol Motil 17 (3): 279–86. doi:10.5056/jnm.2011.17.3.279. PMC 3155064. PMID 21860820.
Dong, YY.; Zuo, XL.; Li, CQ.; Yu, YB.; Zhao, QJ.; Li, YQ. (September 2010). “Prevalence of irritable bowel syndrome in Chinese college and university students assessed using Rome III criteria”. World J Gastroenterol 16 (33): 4221–6. doi:10.3748/wjg.v16.i33.4221. PMC 2932929. PMID 20806442.
Sorouri, M.; Pourhoseingholi, MA.; Vahedi, M.; Safaee, A.; Moghimi-Dehkordi, B.; Pourhoseingholi, A.; Habibi, M.; Zali, MR. (2010). “Functional bowel disorders in Iranian population using Rome III criteria”. Saudi J Gastroenterol 16 (3): 154–60. doi:10.4103/1319-3767.65183. PMC 3003223. PMID 20616409.
Miwa, H. (2008). “Prevalence of irritable bowel syndrome in Japan: Internet survey using Rome III criteria”. Patient Prefer Adherence 2: 143–7. PMC 2770425. PMID 19920955.
Engsbro, AL.; Simren, M.; Bytzer, P. (February 2012). “Short-term stability of subtypes in the irritable bowel syndrome: prospective evaluation using the Rome III classification”. Aliment Pharmacol Ther 35 (3): 350–9. doi:10.1111/j.1365-2036.2011.04948.x. PMID 22176384.
Ersryd, A.; Posserud, I.; Abrahamsson, H.; Simrén, M. (2007-07-02). “Subtyping the irritable bowel syndrome by predominant bowel habit: Rome II versus Rome III”. Alimentary Pharmacology & Therapeutics 26 (6): 953–961. doi:10.1111/j.1365-2036.2007.03422.x. PMID 17767480.
Choung, RS.; Locke, GR.; Zinsmeister, AR.; Schleck, CD.; Talley, NJ. (October 2007). “Epidemiology of slow and fast colonic transit using a scale of stool form in a community”. Aliment Pharmacol Ther 26 (7): 1043–50. doi:10.1111/j.1365-2036.2007.03456.x. PMID 17877511.
Remes-Troche, JM.; Ozturk, R.; Philips, C.; Stessman, M.; Rao, SS. (February 2008). “Cholestyramine--a useful adjunct for the treatment of patients with fecal incontinence”. Int J Colorectal Dis 23 (2): 189–94. doi:10.1007/s00384-007-0391-y. PMID 17938939.
Wang, HJ.; Liang, XM.; Yu, ZL.; Zhou, LY.; Lin, SR.; Geraint, M. (2004). “A Randomised, Controlled Comparison of Low-Dose Polyethylene Glycol 3350 plus Electrolytes with Ispaghula Husk in the Treatment of Adults with Chronic Functional Constipation”. Clin Drug Investig 24 (10): 569–76. doi:10.2165/00044011-200424100-00002. PMID 17523718.
Sakai, T.; Makino, H.; Ishikawa, E.; Oishi, K.; Kushiro, A. (June 2011). “Fermented milk containing Lactobacillus casei strain Shirota reduces incidence of hard or lumpy stools in healthy population”. Int J Food Sci Nutr 62 (4): 423–30. doi:10.3109/09637486.2010.542408. PMID 21322768.
Riezzo, G.; Orlando, A.; D'Attoma, B.; Guerra, V.; Valerio, F.; Lavermicocca, P.; De Candia, S. (February 2012). “Randomised clinical trial: efficacy of Lactobacillus paracasei-enriched artichokes in the treatment of patients with functional constipation - a double-blind, controlled, crossover study”. Aliment Pharmacol Ther 35 (4): 441–50. doi:10.1111/j.1365-2036.2011.04970.x. PMID 22225544.
Park, JE.; Sul, JU.; Kang, K.; Shin, BC.; Hong, KE.; Choi, SM. (2011). “The effectiveness of moxibustion for the treatment of functional constipation: a randomized, sham-controlled, patient blinded, pilot clinical trial”. BMC Complement Altern Med 11: 124. doi:10.1186/1472-6882-11-124. PMC 3248868. PMID 22132755.
Fosnes, GS.; Lydersen, S.; Farup, PG. (2011). “Effectiveness of laxatives in elderly--a cross sectional study in nursing homes”. BMC Geriatr 11: 76. doi:10.1186/1471-2318-11-76. PMC 3226585. PMID 22093137.
Munshi, R.; Bhalerao, S.; Rathi, P.; Kuber, VV.; Nipanikar, SU.; Kadbhane, KP. (July 2011). “An open-label, prospective clinical study to evaluate the efficacy and safety of TLPL/AY/01/2008 in the management of functional constipation”. J Ayurveda Integr Med 2 (3): 144–52. doi:10.4103/0975-9476.85554. PMC 3193686. PMID 22022157.
Pucciani, F.; Raggioli, M.; Ringressi, MN. (December 2011). “Usefulness of psyllium in rehabilitation of obstructed defecation”. Tech Coloproctol 15 (4): 377–83. doi:10.1007/s10151-011-0722-4. PMID 21779973.
Bafutto, M.; Almeida, JR.; Leite, NV.; Oliveira, EC.; Gabriel-Neto, S.; Rezende-Filho, J. (2011). “Treatment of postinfectious irritable bowel syndrome and noninfective irritable bowel syndrome with mesalazine”. Arq Gastroenterol 48 (1): 36–40. doi:10.1590/s0004-28032011000100008. PMID 21537540.
Michna, E.; Blonsky, ER.; Schulman, S.; Tzanis, E.; Manley, A.; Zhang, H.; Iyer, S.; Randazzo, B. (May 2011). “Subcutaneous methylnaltrexone for treatment of opioid-induced constipation in patients with chronic, nonmalignant pain: a randomized controlled study.”. J Pain 12 (5): 554–62. doi:10.1016/j.jpain.2010.11.008. PMID 21429809.
Clemens, KE.; Quednau, I.; Klaschik, E. (April 2011). “Bowel function during pain therapy with oxycodone/naloxone prolonged-release tablets in patients with advanced cancer”. Int J Clin Pract 65 (4): 472–8. doi:10.1111/j.1742-1241.2011.02634.x. PMID 21401835.
Strid, H.; Simrén, M.; Störsrud, S.; Stotzer, PO.; Sadik, R. (June 2011). “Effect of heavy exercise on gastrointestinal transit in endurance athletes”. Scand J Gastroenterol 46 (6): 673–7. doi:10.3109/00365521.2011.558110. PMID 21366388.
“Stool form scale as a useful guide to intestinal transit time”. Scand. J. Gastroenterol. 32 (9): 920–4. (September 1997). doi:10.3109/00365529709011203. PMID 9299672.
Heaton, KW.; Radvan, J.; Cripps, H.; Mountford, RA.; Braddon, FE.; Hughes, AO. (June 1992). “Defecation frequency and timing, and stool form in the general population: a prospective study”. Gut 33 (6): 818–24. doi:10.1136/gut.33.6.818. PMC 1379343. PMID 1624166.
“Evaluation of gastrointestinal transit in clinical practice: position paper of the American and European Neurogastroenterology and Motility Societies”. Neurogastroenterol. Motil. 23 (1): 8–23. (2011). doi:10.1111/j.1365-2982.2010.01612.x. PMID 21138500.
Parés, D.; Comas, M.; Dorcaratto, D.; Araujo, MI.; Vial, M.; Bohle, B.; Pera, M.; Grande, L. (May 2009). “Adaptation and validation of the Bristol scale stool form translated into the Spanish language among health professionals and patients”. Rev Esp Enferm Dig 101 (5): 312–6. doi:10.4321/s1130-01082009000500002. PMID 19527076.
Martinez, AP; de Azevedo, GR. (2012). “The Bristol Stool Form Scale: its translation to Portuguese, cultural adaptation and validation”. Rev Lat Am Enfermagem 20 (3): 583–589. doi:10.1590/S0104-11692012000300021. PMID 22991122.
Wojtyniak, K.; Szajewska, H.; Dziechciarz, P. (2018). “Translation to Polish, cross-cultural adaptation, and validation of the Bristol Stool Form Scale among healthcare professionals and patients” (英語). Prz Gastroenterol 13 (1): 35–39. doi:10.5114/pg.2017.70610. PMC 5894444. PMID 29657609. Fig. 1: Polish BSFS (CC BY-NC-SA 4.0)
Chumpitazi, BP.; Lane, MM.; Czyzewski, DI.; Weidler, EM.; Swank, PR.; Shulman, RJ. (October 2010). “Creation and initial evaluation of a stool form scale for children”. J Pediatr 157 (4): 594–7. doi:10.1016/j.jpeds.2010.04.040. PMC 2937014. PMID 20826285.
Candy, D.; Paul, S. (2011). “Go with the flow: in childhood constipation”. J Fam Health Care 21 (5): 35, 37–8, 40–1 passim. PMID 22132564.
Lane, MM.; Czyzewski, DI.; Chumpitazi, BP.; Shulman, RJ. (September 2011). “Reliability and validity of a modified Bristol Stool Form Scale for children”. J Pediatr 159 (3): 437–441.e1. doi:10.1016/j.jpeds.2011.03.002. PMC 3741451. PMID 21489557.

ncbi.nlm.nih.gov

National Collaborating Centre for Nursing and Supportive Care, (UK) (February 2008). Irritable Bowel Syndrome in Adults: Diagnosis and Management of Irritable Bowel Syndrome in Primary Care, NICE Clinical Guidelines, No. 61. PMID 21656972 2015年11月17日閲覧。.
“Rome Criteria and a Diagnostic Approach to Irritable Bowel Syndrome.”. J Clin Med 6 (11): 99. (2017). doi:10.3390/jcm6110099. PMC 5704116. PMID 29072609.
Park, JM.; Choi, MG.; Cho, YK.; Lee, IS.; Kim, JI.; Kim, SW.; Chung, IS. (July 2011). “Functional Gastrointestinal Disorders Diagnosed by Rome III Questionnaire in Korea”. J Neurogastroenterol Motil 17 (3): 279–86. doi:10.5056/jnm.2011.17.3.279. PMC 3155064. PMID 21860820.
Dong, YY.; Zuo, XL.; Li, CQ.; Yu, YB.; Zhao, QJ.; Li, YQ. (September 2010). “Prevalence of irritable bowel syndrome in Chinese college and university students assessed using Rome III criteria”. World J Gastroenterol 16 (33): 4221–6. doi:10.3748/wjg.v16.i33.4221. PMC 2932929. PMID 20806442.
Sorouri, M.; Pourhoseingholi, MA.; Vahedi, M.; Safaee, A.; Moghimi-Dehkordi, B.; Pourhoseingholi, A.; Habibi, M.; Zali, MR. (2010). “Functional bowel disorders in Iranian population using Rome III criteria”. Saudi J Gastroenterol 16 (3): 154–60. doi:10.4103/1319-3767.65183. PMC 3003223. PMID 20616409.
Miwa, H. (2008). “Prevalence of irritable bowel syndrome in Japan: Internet survey using Rome III criteria”. Patient Prefer Adherence 2: 143–7. PMC 2770425. PMID 19920955.
Park, JE.; Sul, JU.; Kang, K.; Shin, BC.; Hong, KE.; Choi, SM. (2011). “The effectiveness of moxibustion for the treatment of functional constipation: a randomized, sham-controlled, patient blinded, pilot clinical trial”. BMC Complement Altern Med 11: 124. doi:10.1186/1472-6882-11-124. PMC 3248868. PMID 22132755.
Fosnes, GS.; Lydersen, S.; Farup, PG. (2011). “Effectiveness of laxatives in elderly--a cross sectional study in nursing homes”. BMC Geriatr 11: 76. doi:10.1186/1471-2318-11-76. PMC 3226585. PMID 22093137.
Munshi, R.; Bhalerao, S.; Rathi, P.; Kuber, VV.; Nipanikar, SU.; Kadbhane, KP. (July 2011). “An open-label, prospective clinical study to evaluate the efficacy and safety of TLPL/AY/01/2008 in the management of functional constipation”. J Ayurveda Integr Med 2 (3): 144–52. doi:10.4103/0975-9476.85554. PMC 3193686. PMID 22022157.
Heaton, KW.; Radvan, J.; Cripps, H.; Mountford, RA.; Braddon, FE.; Hughes, AO. (June 1992). “Defecation frequency and timing, and stool form in the general population: a prospective study”. Gut 33 (6): 818–24. doi:10.1136/gut.33.6.818. PMC 1379343. PMID 1624166.
Wojtyniak, K.; Szajewska, H.; Dziechciarz, P. (2018). “Translation to Polish, cross-cultural adaptation, and validation of the Bristol Stool Form Scale among healthcare professionals and patients” (英語). Prz Gastroenterol 13 (1): 35–39. doi:10.5114/pg.2017.70610. PMC 5894444. PMID 29657609. Fig. 1: Polish BSFS (CC BY-NC-SA 4.0)
Chumpitazi, BP.; Lane, MM.; Czyzewski, DI.; Weidler, EM.; Swank, PR.; Shulman, RJ. (October 2010). “Creation and initial evaluation of a stool form scale for children”. J Pediatr 157 (4): 594–7. doi:10.1016/j.jpeds.2010.04.040. PMC 2937014. PMID 20826285.
Lane, MM.; Czyzewski, DI.; Chumpitazi, BP.; Shulman, RJ. (September 2011). “Reliability and validity of a modified Bristol Stool Form Scale for children”. J Pediatr 159 (3): 437–441.e1. doi:10.1016/j.jpeds.2011.03.002. PMC 3741451. PMID 21489557.

pmc.ncbi.nlm.nih.gov

“Rome Criteria and a Diagnostic Approach to Irritable Bowel Syndrome.”. J Clin Med 6 (11): 99. (2017). doi:10.3390/jcm6110099. PMC 5704116. PMID 29072609.
Park, JM.; Choi, MG.; Cho, YK.; Lee, IS.; Kim, JI.; Kim, SW.; Chung, IS. (July 2011). “Functional Gastrointestinal Disorders Diagnosed by Rome III Questionnaire in Korea”. J Neurogastroenterol Motil 17 (3): 279–86. doi:10.5056/jnm.2011.17.3.279. PMC 3155064. PMID 21860820.
Dong, YY.; Zuo, XL.; Li, CQ.; Yu, YB.; Zhao, QJ.; Li, YQ. (September 2010). “Prevalence of irritable bowel syndrome in Chinese college and university students assessed using Rome III criteria”. World J Gastroenterol 16 (33): 4221–6. doi:10.3748/wjg.v16.i33.4221. PMC 2932929. PMID 20806442.
Sorouri, M.; Pourhoseingholi, MA.; Vahedi, M.; Safaee, A.; Moghimi-Dehkordi, B.; Pourhoseingholi, A.; Habibi, M.; Zali, MR. (2010). “Functional bowel disorders in Iranian population using Rome III criteria”. Saudi J Gastroenterol 16 (3): 154–60. doi:10.4103/1319-3767.65183. PMC 3003223. PMID 20616409.
Miwa, H. (2008). “Prevalence of irritable bowel syndrome in Japan: Internet survey using Rome III criteria”. Patient Prefer Adherence 2: 143–7. PMC 2770425. PMID 19920955.
Park, JE.; Sul, JU.; Kang, K.; Shin, BC.; Hong, KE.; Choi, SM. (2011). “The effectiveness of moxibustion for the treatment of functional constipation: a randomized, sham-controlled, patient blinded, pilot clinical trial”. BMC Complement Altern Med 11: 124. doi:10.1186/1472-6882-11-124. PMC 3248868. PMID 22132755.
Fosnes, GS.; Lydersen, S.; Farup, PG. (2011). “Effectiveness of laxatives in elderly--a cross sectional study in nursing homes”. BMC Geriatr 11: 76. doi:10.1186/1471-2318-11-76. PMC 3226585. PMID 22093137.
Munshi, R.; Bhalerao, S.; Rathi, P.; Kuber, VV.; Nipanikar, SU.; Kadbhane, KP. (July 2011). “An open-label, prospective clinical study to evaluate the efficacy and safety of TLPL/AY/01/2008 in the management of functional constipation”. J Ayurveda Integr Med 2 (3): 144–52. doi:10.4103/0975-9476.85554. PMC 3193686. PMID 22022157.
Heaton, KW.; Radvan, J.; Cripps, H.; Mountford, RA.; Braddon, FE.; Hughes, AO. (June 1992). “Defecation frequency and timing, and stool form in the general population: a prospective study”. Gut 33 (6): 818–24. doi:10.1136/gut.33.6.818. PMC 1379343. PMID 1624166.
Wojtyniak, K.; Szajewska, H.; Dziechciarz, P. (2018). “Translation to Polish, cross-cultural adaptation, and validation of the Bristol Stool Form Scale among healthcare professionals and patients” (英語). Prz Gastroenterol 13 (1): 35–39. doi:10.5114/pg.2017.70610. PMC 5894444. PMID 29657609. Fig. 1: Polish BSFS (CC BY-NC-SA 4.0)
Chumpitazi, BP.; Lane, MM.; Czyzewski, DI.; Weidler, EM.; Swank, PR.; Shulman, RJ. (October 2010). “Creation and initial evaluation of a stool form scale for children”. J Pediatr 157 (4): 594–7. doi:10.1016/j.jpeds.2010.04.040. PMC 2937014. PMID 20826285.
Lane, MM.; Czyzewski, DI.; Chumpitazi, BP.; Shulman, RJ. (September 2011). “Reliability and validity of a modified Bristol Stool Form Scale for children”. J Pediatr 159 (3): 437–441.e1. doi:10.1016/j.jpeds.2011.03.002. PMC 3741451. PMID 21489557.

umich.edu

deepblue.lib.umich.edu

“Evaluation of gastrointestinal transit in clinical practice: position paper of the American and European Neurogastroenterology and Motility Societies”. Neurogastroenterol. Motil. 23 (1): 8–23. (2011). doi:10.1111/j.1365-2982.2010.01612.x. PMID 21138500.